ArticleJournal of clinical laboratory analysis2025
Clinical Application of Using Diffusion-Based Wasserstein Generative Adversarial Network for Morphologic Analysis of Blood Cells.
Article in Journal of clinical laboratory analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMorphologic analysis of peripheral blood smears is essential for diagnosing hematologic diseases and patient management. Although manual microscopy is the traditional gold standard, it is time-consuming and subjective. Digital morphology analyzers have improved automation and accuracy; however, challenges remain, particularly in classifying certain cell types. Recently, the diffusion-based Wasserstein generative adversarial network with gradient penalty (DWGAN-GP) showed potential by enhancing image quality and addressing data imbalance. We aim to investigate the accuracy of blood cell classification using the DWGAN-GP model.
methodsIn this study, the DWGAN-GP model in conjunction with the EfficientNetB3 classification model was evaluated using 78,494 peripheral blood cell images. Samples were collected from patients with normal and abnormal hematologic conditions. Data were balanced by augmenting underrepresented classes with synthetic images, resulting in equal representation across 13 cell classes. Performance was compared with PBIA (ANI Co., Suwon, Korea), a commercial digital morphology analyzer.
resultsDWGAN-GP augmentation significantly improved classification accuracy of the EfficientNetB3 model to 97.74% with an F1-score of 91.13%. This result surpassed both the unbalanced dataset (accuracy 95.68%, F1-score 82.12%) and PBIA system (accuracy 95%). Notably, improvements were significant in minority classes such as blasts and myelocytes, which are critical in diagnosing leukemia.
conclusionIncorporating synthetic data using DWGAN-GP significantly enhanced model performance and addressed class imbalance. This method shows promise for more accurate and consistent blood cell classification, offering potential improvements in clinical diagnostics for hematologic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.